Rationality of plasma exchange therapy based on periodic liver CT volume calculation in patients with fulminant hepatitis
Kukita, K.; Kawamura, A.; Ariyama, T.; Meguro, J.; Yonekawa, M.; Imai, K.; Seto, K.; Kobayashi, N.; Kawamura, K.; Higa, T.
Progress in Clinical and Biological Research 337: 237-238
1990
ISSN/ISBN: 0361-7742 PMID: 2191315 Document Number: 364621
Document emailed within 1 workday
Related Documents
Fujiwara, S.; Okawa, K.; Mizoguchi, R.; Watanabe, K. 1977: Nursing of a patient with fulminant hepatitis--on the patient treated with plasma exchange and an artificial liver Kango Tenbo. Japanese Journal of Nursing Science 2(9): 48-52Chen, G.-c.; Zhang, S.-c. 2010: Prognosis comparison in middle and later stage severe hepatitis B patients treat with plasma exchange or unified medicine therapy Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 24(5): 370-372
Larsen, F.S.; Kirkegaard, P.; Hjortrup, A.; Dickmeiss, E.; Hansen, B.A. 1994: High-volume plasma exchange and hyperacute rejection in ABO incompatible acute liver transplantation Transplantation Proceedings 26(3): 1789
Ockelford, P.A.; Lowe, G.; Johns, A.S.; Berry, E.W. 1986: Comparison of methods of plasma volume determination for dose calculation of factor VIII in patients with classic haemophilia New Zealand Medical Journal 99(796): 116-119
Bojić, I. 1996: Use of extracorporeal hybrid (natural-artificial) liver in the treatment of patients with fulminant hepatitis Vojnosanitetski Pregled 53(2): 133-136
Macías, J.; Mira, J.é A.; López-Cortés, L.F.; Santos, I.; Girón-González, J.é A.; González-Serrano, M.; Merino, D.; Hernández-Quero, J.é; Rivero, A.; Merchante, N.ás.; Trastoy, M.ón.; Carrillo-Gómez, R.; Arizcorreta-Yarza, A.; Gómez-Mateos, J.ús.; Pineda, J.A. 2006: Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C Antiviral Therapy 11(7): 839-846
Yu, J.-W.; Wang, G.-Q.; Zhao, Y.-H.; Sun, L.-J.; Wang, S.-Q.; Li, S.-C. 2007: The MELD scoring system for predicting prognosis in patients with severe hepatitis after plasma exchange treatment Hepatobiliary and Pancreatic Diseases International: Hbpd Int 6(5): 492-496
Aydin, H.; Richter, E.; Feyerabend, T.; Bohndorf, W. 1990: In vivo determination of tumor volume: what does a CT-based calculation mean in recurrences of rectal carcinoma? Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 166(3): 204-206
Ye, J.L.; Ye, B.; Lv, J.X.; Mao, W.L.; Gu, B. 2014: Changes of ammonia levels in patients with acute on chronic liver failure treated by plasma exchange Hepato-Gastroenterology 61(129): 141-145
Guidet, B.; Luquel, L.; De Labriolle Vaylet, C.; Offenstadt, G. 1987: Hemodynamic tolerance and plasma volume variations during plasma exchange. Replacement fluid: albumin alone or albumin plus gelatin? International Journal of Artificial Organs 10(5): 325-330
Bláha, M.; Pidrman, V.; Jebavý, L.; Vanásek, J.; Maly, J.; Pecka, M.; Siroký, O. 1984: Methods of replacing circulating volume in plasma exchange Casopis Lekaru Ceskych 123(21): 642-645
Sherman, K.E.; Shire, N.J.; Cernohous, P.; Rouster, S.D.; Omachi, J.H.; Brun, S.; Da Silva, B. 2005: Liver injury and changes in hepatitis C virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients : Lopinavir-ritonavir versus nelfinavir Clinical Infectious Diseases 41(8): 1186-1195
Nusinovici, V.; Crubille, C.; Opolon, P.; Touboul, J.P.; Darnis, F.; Caroli, J. 1977: Fulminant hepatitis: an experience based on 137 cases. II. Course and prognosis Gastroenterologie Clinique et Biologique 1(11): 875-886
Azuma, N.; Kamano, T.; Yuasa, S.; Tamura, J.; Katami, A.; Sato, T.; Kishino, H.; Mizukami, K.; Kidokoro, T. 1984: Clinical trials of plasma exchange therapy in patients with recurrent colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(9): 1801-1808
Guo, Y.; Lu, Q.; Luo, K. 1999: Hepatitis B virus core promoter mutations in patients with fulminant hepatitis Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 13(3): 251-254
Ehrmann, J.; Kucerova, L.; Jezdinská, V.; Papajík, T.; Galuzsková, D.; Dusek, J.; Indrák, K.; Krc, I.; Ehrmann, J. 1996: Fulminant hepatitis caused by a hepatitis B virus infection in the patients with haematologic malignancies. Report of 5 cases Acta Universitatis Palackianae Olomucensis Facultatis Medicae 140: 81-82
Drivenes, A.; Bjøro, K.; Holter, E.; Bentdal, Øy.; Boberg, K.M. 2003: Fulminant liver failure in acute hepatitis B virus infection Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 123(2): 172-174
Tsutsui, H.; Mizoguchi, Y.; Morisawa, S. 1992: Importance of direct hepatocytolysis by liver macrophages in experimental fulminant hepatitis Hepato-Gastroenterology 39(6): 553-559
Li, X.-m.; Deng, L.-z.; Shen, H.-m.; Yang, Y.-b.; Li, M.-x.; Chen, X.-w.; Yin, Y.-z.; Zhou, S.-s. 2007: Liver synthetic function in predicting the prognosis of pregnancy complicating fulminant hepatitis Chinese Medical Journal 120(24): 2311-2313
Winkler, M.; Ringe, B.; Jost, U.; Gubernatis, G.; Pichlmayr, R. 1993: Plasma level-guided low-dose FK 506 therapy in patients with early liver dysfunction after liver transplantation Transplantation Proceedings 25(4): 2688-2690